Sign In

Charles Keller

Scientific Director, Children's Cancer Therapy Development Institute (cc-TDI.org)

Charles Keller is a renowned expert in childhood cancers, focusing on developing less toxic therapies for advanced diseases.

He is actively involved in organizations like Children's Oncology Group and National Cancer Institute, contributing significantly to the field.

With a background in Biomedical Engineering and a Doctor of Medicine degree, Charles has a strong academic foundation from Tulane University and Baylor College of Medicine.

Having completed his fellowship in Pediatric Hematology-Oncology at the University of Utah, Charles is a prolific author with over 140 scientific publications.

In his spare time, he enjoys outdoor adventures with his daughters and engages in designing and building treehouses and unique structures.

Highlights

'Silicon Forest' lab gets a piece of a $25M global children's cancer initiative grant - The Business Journals
'Silicon Forest' lab gets a piece of a $25M global children's cancer initiative grant - The Business
Sep 1 · Nature.com
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma ... - Nature.com
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma ... - Nature.com
Charles Keller
Add to my network

Location

Portland, Oregon Metropolitan Area